OrbiMed Advisors IV Ltd
- SEC CIK
- 0001966835
No open-market purchases or sales filed in the past year.
Current role at each company
- KNTE Kinnate Biopharma Inc.Director, 10% Owneras of Apr 5, 2024
- AVBP ArriVent BioPharma, Inc.Director, 10% Owneras of Jan 31, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Advisors IV Ltd as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVBP ArriVent BioPharma, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 (view filing)4:12 PM ET | Jan 30 | 1 day | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +444.4K | $18.00 | +$8.00M | +41.6%1.51M after | 2 lotsDuplicate filing |
KNTE Kinnate Biopharma Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 (view filing)5:22 PM ET | May 4-5 | 4 days | OrbiMed Advisors LLC and 6 othersDirector, 10% Owner | PPurchase | +1.46M | $2.80 | +$4.09M | New position1.37M after | 5 lotsDuplicate filing |
| May 2, 2023 (view filing)9:34 PM ET | Apr 28-May 2 | 4 days | OrbiMed Advisors LLC and 6 othersDirector, 10% Owner | PPurchase | +1.41M | $2.61 | +$3.67M | New position794.4K after | 9 lotsDuplicate filing |